Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Quince Therapeutics, Inc. | 225,000 | reported | 01 Feb 2023 | tx 5+1,936,938 |
| Context Therapeutics Inc. | 123,500 | reported | 12 Jun 2025 | tx 2+142,815 |
| SANGAMO THERAPEUTICS, INC | 50,000 | reported | 12 Jun 2025 | tx 18+353,750 |
| Skye Bioscience, Inc. | 35,000 | reported | 06 Feb 2026 | tx 4+180,000 |
| Jazz Pharmaceuticals plc | 28,474 | reported | 05 Mar 2018 | tx 25+105,380−3,129 |
| Talaris Therapeutics, Inc. | 20,500 | reported | 13 Jun 2023 | tx 3+64,003 |
| Aurinia Pharmaceuticals Inc. | 18,641 | reported | 21 Nov 2024 | tx 7+95,561−23,154 |
| Emergent BioSolutions Inc. | 11,888 | reported | 07 May 2021 | tx 4+17,648−305 |
| Sucampo Pharmaceuticals, Inc. | 0 | reported | 13 Feb 2018 | tx 1−30,000 |
| ANTARES PHARMA INC | 0 | reported | 24 May 2022 | tx 13+253,162−253,162 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Feb 2026 | GRANT_AWARD | Skye Bioscience, Inc. | 35,000 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 25,000 | 0.00 USD | |
| 12 Jun 2025 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 50,000 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Context Therapeutics Inc. | 123,500 | 0.00 USD | deriv |
| 24 Feb 2025 | GRANT_AWARD | Skye Bioscience, Inc. | 35,000 | 0.00 USD | deriv |
| 21 Nov 2024 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 12,135 | 0.00 USD | |
| 21 Nov 2024 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 18,641 | 0.00 USD | deriv |
| 08 Nov 2024 | EXERCISE | Aurinia Pharmaceuticals Inc. | 17,913 | — | |
| 11 Nov 2024 | SALE | Aurinia Pharmaceuticals Inc. | 5,241 | 8.43 USD | |
| 08 Nov 2024 | EXERCISE | Aurinia Pharmaceuticals Inc. | 17,913 | 0.00 USD | deriv |
| 28 Oct 2024 | GRANT_AWARD | Skye Bioscience, Inc. | 70,000 | 0.00 USD | deriv |
| 04 Sept 2024 | GRANT_AWARD | Context Therapeutics Inc. | 19,315 | 0.00 USD | deriv |
| 02 Jul 2024 | GRANT_AWARD | Skye Bioscience, Inc. | 40,000 | 0.00 USD | deriv |
| 04 Jun 2024 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 25,000 | 0.00 USD | |
| 04 Jun 2024 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 50,000 | 0.00 USD | deriv |
| 18 Aug 2023 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 28,959 | 0.00 USD | deriv |
| 18 Aug 2023 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 17,913 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 20,500 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 13,900 | 0.00 USD | |
| 01 Jun 2023 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 27,750 | 0.00 USD | deriv |
| 01 Feb 2023 | GRANT_AWARD | Quince Therapeutics, Inc. | 225,000 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | Talaris Therapeutics, Inc. | 14,501 | 0.00 USD | deriv |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 25,452 | 5.60 USD | |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 54,193 | 5.60 USD | |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 58,246 | — | deriv |